NEW YORK (GenomeWeb) – Merck today announced it would join the Structural Genomics Consortium (SGC) by making a C$7.5 million (US$6 million) contribution to the network.

The investment supports research projects to develop molecular probes to study epigenetic mechanisms of gene regulation. Use of the probes will expand the understanding of biology in multiple disease areas, particularly cancer and inflammatory diseases, the firm said in a statement.

Merck and SGC said that the supported projects "focus on precompetitive research to develop" the chemical probes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.